Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
REVENUES:        
Revenues $ 41,090,137 $ 20,680,550 $ 104,098,237 $ 54,559,758
Cost of product revenue 31,433,496 20,295,213 83,010,156 56,897,959
Gross profit (loss) 9,656,641 385,337 21,088,081 (2,338,201)
OPERATING EXPENSES:        
Research and development 1,041,947 770,557 2,539,444 2,917,072
Plasma center operating expenses 4,859,450 3,146,221 12,755,525 8,191,890
Amortization of intangible assets 178,838 178,838 536,514 536,514
Selling, general and administrative 12,893,139 10,726,797 38,563,136 31,198,880
Total operating expenses 18,973,374 14,822,413 54,394,619 42,844,356
LOSS FROM OPERATIONS (9,316,733) (14,437,076) (33,306,538) (45,182,557)
OTHER INCOME (EXPENSE):        
Interest income 7,236 4,256 42,573 32,241
Interest expense (5,580,366) (3,298,680) (13,542,419) (9,741,110)
Loss on extinguishment of debt 0 0 (6,669,941) 0
Other expense (9,641) 18,546 (195,942) (106,772)
Other expense, net (5,582,771) (3,275,878) (20,365,729) (9,815,641)
NET LOSS $ (14,899,504) $ (17,712,954) $ (53,672,267) $ (54,998,198)
BASIC LOSS PER COMMON SHARE (in dollars per share) $ (0.08) $ (0.13) $ (0.27) $ (0.44)
DILUTED LOSS PER COMMON SHARE (in dollars per share) $ (0.08) $ (0.13) $ (0.27) $ (0.44)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic (in shares) 196,383,935 133,770,147 196,204,893 125,682,400
Diluted (in shares) 196,383,935 133,770,147 196,204,893 125,682,400
Product Revenue [Member]        
REVENUES:        
Revenues $ 41,054,429 $ 20,644,842 $ 103,991,112 $ 54,452,633
License Revenue [Member]        
REVENUES:        
Revenues $ 35,708 $ 35,708 $ 107,125 $ 107,125